Floridienne S.A.

Report Publication Announcement • Nov 29, 2021

Floridienne Group - Press release – Regulated information – Embargo 29 November 2021 5.40 pm Transmitted on 29 November 2021 5.40 pm

INTERIM STATEMENT

Financial statements as at 30 September 2021

The Floridienne Group reports a sharp rise in its operating result as at the end of September thanks to the development of its three Divisions.

The Life Sciences Division is benefiting from strong demand on its main markets and reports growth in sales and results over the first nine months of the financial year. BIOBEST is benefiting from the success of its pest management solutions and the positive integration of its recent acquisitions: BENEFICIAL INSECTARY (United States, company acquired in November 2020) and BIOLOGICAL SERVICES (Australia, majority shareholding acquired in April 2021). ENZYBEL is having to respond to growth in demand among its main customers and is therefore investing heavily to optimise its production processes and increase production capacity for its plant and animal enzymes.

As previously announced, BIOBEST has entered into exclusive negotiations with a view to acquiring most of the shares in a leading player in its sector. The target represents sales in excess of € 100 million and the transaction involves a business value of a similar amount. BIOBEST is currently continuing with the negotiations, carrying out the pre-acquisition audit and organising the financing needed to complete this transaction in the first quarter of 2022.

The Gourmet Food Division recorded a substantial increase in its operating performance in the first nine months of the year thanks to the development of its specialities market and the improvement in its profitability. The growth in mass retail sales offset the downturn seen in activity in the hospitality sector owing to the continuation of the health measures in force on its main markets. The Division is keeping a close eye on inflation indicators and will immediately take the measures necessary to maintain its profitability.

Finally, in the Chemicals Division the operating result is sharply up thanks mainly to our recycling activity (SNAM), which is benefiting from the increase in the volumes of batteries collected and more advantageous purified metals prices. The € 10 million capital increase finalised with a German investor on 15 November 2021 provides SNAM with the means to speed up its ambitious investment programme so as to respond to the substantial growth in the volumes of batteries from electric mobility. KIMFLOR, our subsidiary active in the field of PVC stabilisers in Turkey, is developing positively despite a difficult environment.

"The forecasts for the last quarter of 2021 are generally positive, maintaining the trends seen at the end of September: significant growth in the Life Sciences Division, improved profitability in the Gourmet Food Division and an excellent performance from our recycling activities in the Chemicals Division. The FLORIDIENNE Board of Directors is therefore maintaining its forecasts for a sharp growth in results for the 2021 financial year as a whole." said Gaëtan Waucquez, CEO of the Floridienne Group.

Floridienne Group - Press release – Regulated information – Embargo 29 November 2021 5.40 pm Transmitted on 29 November 2021 5.40 pm

Financial calendar

Annual results 2021 31 March 2022 First interim statement 27 May 2022 Ordinary General Meeting 7 June 2022

****************

Contacts:

Marc Blanpain, Chairman Gaëtan Waucquez, CEO

FLORIDIENNE is a Belgian industrial group listed on the Euronext Brussels stock market that ranks among the European or world leaders in market niches or niche markets. Its activities focus on three sectors: Gourmet Food, Life Sciences and Chemicals.